The academic editor of PLOS ONE informed us yesterday that our latest paper ‘Life-time experience of violence among women and girls living with disability in Nepal: A cross-sectional study’ [1] has been accepted for publication. The paper is based on research conducted as part of the Inclusive Partnership Against Violence (INPAV) project in Nepal.
Working with our long-term research paper Green Tara Nepal (GTN) and funded by The United Nations Trust Fund (UNTF) through Nepal Disabled Women Association (NDWA), we have been involved in InPAV. This project included a situation analysis of the existing government setup One-stop Crisis Management Center (OCMC) to understand the inclusiveness of the OCMC services for girls and women with disabilities. The paper just accepted was part of this research.
Centre for Midwifery & Women’s Health
- Simkhada, P., Basnet, S., Sharma, S., van Teijlingen, E., Wasti, S.P., Dahal, T., Okyere, J., Silwal, R.C., Pyakurel, M. (2025) Life-time experience of violence among women and girls living with disability in Nepal: A cross-sectional study . PLoS ONE (accepted).

Newly accepted paper on Nepal in BMJ Open
New BU women’s health workers’ paper
New migration paper related to Nepal
New Bournemouth University public health paper










ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
First publication for two CMWH PhD students
Opportunities to support our REF preparations
SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease